Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 453046, 11 pages
http://dx.doi.org/10.1155/2015/453046
Research Article

Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives

1Southern Iron Disorders Center, Birmingham, AL 35209, USA
2Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35209, USA

Received 18 June 2015; Accepted 2 August 2015

Academic Editor: Fulvia Ceccarelli

Copyright © 2015 James C. Barton and J. Clayborn Barton. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Finch and C. A. Finch, “Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis,” Medicine, vol. 34, no. 4, pp. 381–430, 1955. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Q. Edwards and J. C. Barton, “Hemochromatosis,” in Wintrobe's Clinical Hematology, J. P. Greer, D. A. Arber, B. Glader et al., Eds., chapter 25, pp. 662–681, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2014. View at Google Scholar
  3. M. Simon, Y. Pawlotsky, M. Bourel, R. Fauchet, and B. Genetet, “Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen,” La Nouvelle Presse Médicale, vol. 4, no. 19, article 1432, 1975. View at Google Scholar · View at Scopus
  4. M. Simon, M. Bourel, R. Fauchet, and B. Genetet, “Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis,” Gut, vol. 17, no. 5, pp. 332–334, 1976. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Q. Edwards, L. M. Griffin, D. Goldgar, C. Drummond, M. H. Skolnick, and J. P. Kushner, “Prevalence of hemochromatosis among 11,065 presumably healthy blood donors,” The New England Journal of Medicine, vol. 318, no. 21, pp. 1355–1362, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. J. N. Feder, A. Gnirke, W. Thomas et al., “A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis,” Nature Genetics, vol. 13, no. 4, pp. 399–408, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Barton and R. T. Acton, “HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama,” BMC Medical Genetics, vol. 3, article 9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Costa, E. Cruz, J. C. Barton et al., “Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas,” PLoS ONE, vol. 8, no. 11, Article ID e79990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Simon, L. Le Mignon, R. Fauchet et al., “A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) Mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) Hypothesis concerning the underlying cause of hemochromatosis-HLA association,” American Journal of Human Genetics, vol. 41, no. 2, pp. 89–105, 1987. View at Google Scholar · View at Scopus
  10. R. Pratiwi, L. M. Fletcher, W. R. Pyper et al., “Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression,” Journal of Hepatology, vol. 31, no. 1, pp. 39–46, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Barton, J. C. Barton, and R. T. Acton, “Longer survival associated with HLA-A03, B14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping,” European Journal of Haematology, vol. 85, no. 5, pp. 439–447, 2010. View at Google Scholar
  12. K. S. Olsson, B. Ritter, and N. Hansson, “The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?” European Journal of Haematology, vol. 79, no. 5, pp. 429–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. S. Olsson, B. Ritter, and R. Raha-Chowdhury, “HLA-A3-B14 and the origin of the haemochromatosis C282Y mutation: founder effects and recombination events during 12 generations in a Scandinavian family with major iron overload,” European Journal of Haematology, vol. 84, no. 2, pp. 145–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Siddoo, “Acquired hemolytic anemia associated with hemochromatosis,” Archives of Internal Medicine, vol. 93, no. 6, pp. 977–981, 1954. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Perdrup and H. Poulsen, “Hemochromatosis and vitiligo,” Archives of Dermatology, vol. 90, pp. 34–37, 1964. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Q. Edwards, T. M. Kelly, G. Ellwein, and J. P. Kushner, “Thyroid disease in hemochromatosis. Increased incidence in homozygous men,” Archives of Internal Medicine, vol. 143, no. 10, pp. 1890–1893, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. W. E. Morris Jr., “Hemochromatosis and celiac sprue. Case report,” Journal of the Florida Medical Association, vol. 80, no. 4, pp. 243–245, 1993. View at Google Scholar · View at Scopus
  18. J. C. Barton, B. M. McGuire, and R. T. Acton, “HFE hemochromatosis and hepatic sarcoid,” The American Journal of the Medical Sciences, vol. 337, no. 5, pp. 386–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Ludvigsson, J. A. Murray, P. C. Adams, and M. Elmberg, “Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients,” Scandinavian Journal of Gastroenterology, vol. 48, no. 2, pp. 176–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. C. Adams and J. C. Barton, “How I treat hemochromatosis,” Blood, vol. 116, no. 3, pp. 317–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Publisher · View at Google Scholar
  22. J. C. Barton, J. C. Barton, R. T. Acton, J. So, S. Chan, and P. C. Adams, “Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis,” Clinical Gastroenterology and Hepatology, vol. 10, no. 4, pp. 412–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. Scheuer, R. Williams, and A. R. Muir, “Hepatic pathology in relatives of patients with haemochromatosis,” The Journal of Pathology and Bacteriology, vol. 84, no. 1, pp. 53–64, 1962. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Barton, W. W. H. Shih, R. Sawada-Hirai et al., “Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis,” Blood Cells, Molecules, and Diseases, vol. 23, no. 1, pp. 135–145, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. G. King and L. Zeng, “Logistic regression in rare events data,” Political Analysis, vol. 9, no. 2, pp. 137–163, 2001. View at Publisher · View at Google Scholar
  26. M. A. Heneghan, K. M. Feeley, F. M. Stevens, M. P. G. Little, and C. F. McCarthy, “Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease,” American Journal of Gastroenterology, vol. 95, no. 1, pp. 298–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Turcu, L. Lévêque, P. Bielefeld, J.-F. Besancenot, and P. Hillon, “Adult celiac disease and hemochromatosis,” The American Journal of Gastroenterology, vol. 95, no. 12, pp. 3661–3662, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Geier, C. Gartung, I. Theurl et al., “Occult celiac disease prevents penetrance of hemochromatosis,” World Journal of Gastroenterology, vol. 11, no. 21, pp. 3323–3326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Zubizarreta, E. Zapata, and A. Castiella, “Celiac disease and hemochromatosis,” European Journal of Gastroenterology and Hepatology, vol. 20, no. 6, p. 589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Ellervik, T. Mandrup-Poulsen, A. Tybjærg-Hansen, and B. G. Nordestgaard, “Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies,” Diabetes Care, vol. 37, no. 2, pp. 444–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Tamagno, E. De Carlo, G. Murialdo, and C. Scandellari, “A possible link between genetic hemochromatosis and autoimmune thyroiditis,” Minerva Medica, vol. 98, no. 6, pp. 769–772, 2007. View at Google Scholar · View at Scopus
  32. C. M. Dayan and G. H. Daniels, “Chronic autoimmune thyroiditis,” The New England Journal of Medicine, vol. 335, no. 2, pp. 99–107, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. E. C. Somers, S. L. Thomas, L. Smeeth, and A. J. Hall, “Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?” American Journal of Epidemiology, vol. 169, no. 6, pp. 749–755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. L. Friedland and P. Schaefer, “Hemochromatosis, thrombocytopenic purpura, and multiple endocrine disturbances. An unusual association of uncommon disorders is reported,” Rhode Island Medical Journal, vol. 63, no. 9, pp. 342–344, 1980. View at Google Scholar · View at Scopus
  35. M. E. Herford, “Haemochromatosis, diabetes, and hyperthyroidism,” British Medical Journal, vol. 3, no. 5666, article 359, 1969. View at Publisher · View at Google Scholar · View at Scopus
  36. P. C. Adams, “Hereditary hemochromatosis and red cell aplasia,” American Journal of Hematology, vol. 45, no. 3, pp. 260–261, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Attout, S. Guez, and C. Sériès, “Association of hereditary hemochromatosis and pernicious anaemia,” La Revue de Médecine Interne, vol. 25, no. 10, pp. 759–761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Bonafoux, L. Henry, C. Delfour et al., “Association of familial pernicious anaemia and hereditary haemochromatosis,” Acta Haematologica, vol. 119, no. 1, pp. 12–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Mathew, M. Y. Leong, N. Morley, and A. D. Burt, “A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis,” BMC Dermatology, vol. 5, article 12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Schedel, A. Wimmer, A. Friedrich, R. Büttner, J. Schölmerich, and U. Müller-Ladner, “Unusual co-incidence of Heberden's and Bouchard's osteoarthritis, rheumatoid arthritis and haemochromatosis,” Rheumatology, vol. 42, no. 9, pp. 1109–1111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Wernicke, E. Seipelt, W. A. Schmidt, and E. Gromnica-Ihle, “Manifestation of rheumatoid arthritis in a patient with hereditary haemochromatosis,” Rheumatology International, vol. 26, no. 10, pp. 939–941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. R. W. Dunlap Jr., G. A. Hallenbeck, and D. G. Hanlon, “Portal hypertension with sarcoidosis and with hemochromatosis: report of 2 cases with splenectomy and splenorenal anastomosis,” Proceedings of the Staff Meetings of the Mayo Clinic, vol. 27, no. 14, pp. 266–272, 1952. View at Google Scholar
  43. M. van Deuren, J. J. C. Kroot, and D. W. Swinkels, “Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist,” Haematologica, vol. 94, no. 9, pp. 1297–1300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Y. Ponsioen, P. C. F. Stokkers, A. R. V. Horst, G. N. J. Tytgat, and S. J. H. Van Deventer, “A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects,” European Journal of Internal Medicine, vol. 12, no. 6, pp. 518–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. K. R. Parisian, T. P. Plesec, K. D. Fairbanks, A. S. Tavill, and B. Shen, “Concomitant presentation of collagenous sprue and HFE hemochromatosis,” Journal of Crohn's and Colitis, vol. 5, no. 4, pp. 369–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Candore, D. Lio, G. C. Romano, and C. Caruso, “Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions,” Autoimmunity Reviews, vol. 1, no. 1-2, pp. 29–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. G. S. Cooper, M. L. K. Bynum, and E. C. Somers, “Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases,” Journal of Autoimmunity, vol. 33, no. 3-4, pp. 197–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. W. W. Eaton, N. R. Rose, A. Kalaydjian, M. G. Pedersen, and P. B. Mortensen, “Epidemiology of autoimmune diseases in Denmark,” Journal of Autoimmunity, vol. 29, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. J. Schweizer, B. M. E. von Blomberg, H. B. Bueno-de Mesquita, and M. L. Mearin, “Coeliac disease in the Netherlands,” Scandinavian Journal of Gastroenterology, vol. 39, no. 4, pp. 359–364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. D. L. Jacobson, S. J. Gange, N. R. Rose, and N. M. H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Åsberg, K. Hveem, Ø. Krüger, and K. S. Bjerve, “Persons with screening-detected haemochromatosis: as healthy as the general population?” Scandinavian Journal of Gastroenterology, vol. 37, no. 6, pp. 719–724, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. J. C. Barton, C. Leiendecker-Foster, D. M. Reboussin, P. C. Adams, R. T. Acton, and J. H. Eckfeldt, “Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS Study,” Thyroid, vol. 18, no. 8, pp. 831–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Staii, S. Mirocha, K. Todorova-Koteva, S. Glinberg, and J. C. Jaume, “Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state,” Thyroid Research, vol. 3, no. 1, article 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Kaplan, E. N. Pearce, and A. P. Fairwell, “Thyroiditis,” in Oxford Textbook of Endocrinology and Diabetes, J. A. H. Wass and P. M. Stewart, Eds., chapter 3.2.7, pp. 432–440, Oxford University Press, Oxford, UK, 2011. View at Google Scholar
  55. M. J. Simmonds, F. K. Kavvoura, O. J. Brand et al., “Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 1, pp. E127–E131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. J. H. Sheldon, Haemochromatosis, Oxford University Press, London, UK, 1935.
  57. A. J. Silman and M. C. Hochberg, Epidemiology of the Rheumatic Diseases, Oxford University Press, New York, NY, USA, 2001.
  58. C. G. Helmick, D. T. Felson, R. C. Lawrence et al., “Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I,” Arthritis & Rheumatism, vol. 58, no. 1, pp. 15–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Rull and R. Schumacher Jr., “The arthropathy of hemochromatosis,” in Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, J. C. Barton and C. Q. Edwards, Eds., chapter 24, pp. 258–267, Cambridge University Press, Cambridge, UK, 2000. View at Google Scholar
  60. L. E. Dean, G. T. Jones, A. G. MacDonald, C. Downham, R. D. Sturrock, and G. J. Macfarlane, “Global prevalence of ankylosing spondylitis,” Rheumatology, vol. 53, no. 4, pp. 650–657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Khan, W. E. Braun, I. Kushner, D. E. Grecek, W. A. Muir, and A. G. Steinberg, “HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians,” Journal of Rheumatology Supplement, vol. 3, pp. 339–343, 1977. View at Google Scholar
  62. J. D. Reveille, “HLA-B27 and the seronegative spondyloarthropathies,” The American Journal of the Medical Sciences, vol. 316, no. 4, pp. 239–249, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. E. G. Bywaters, E. B. Hamilton, and R. Williams, “The spine in idiopathic haemochromatosis,” Annals of the Rheumatic Diseases, vol. 30, no. 5, pp. 453–465, 1971. View at Publisher · View at Google Scholar · View at Scopus
  64. C. H. Walsh, “Non-diabetic endocrinopathy in hemochromatosis,” in Hemochromatosis: Genetics, Pathogenesis, Diagnosis and Treatment, J. C. Barton and C. Q. Edwards, Eds., chapter 26, pp. 278–289, Cambridge University Press, Cambridge, UK, 2000. View at Google Scholar
  65. R. A. MacDonald and G. K. Mallory, “Hemochromatosis and hemosiderosis. Study of 211 autopsied cases,” Archives of Internal Medicine, vol. 105, pp. 686–700, 1960. View at Publisher · View at Google Scholar · View at Scopus
  66. W. R. Bezwoda, Bothwell, and L. A. van der Walt, “An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis,” Clinical Endocrinology, vol. 6, no. 5, pp. 377–385, 1977. View at Google Scholar · View at Scopus
  67. C. Varela, A. Hurtado, D. Boixeda et al., “Gonadal and pituitary function in idiopathic hemochromatosis,” Medicina Clinica, vol. 81, no. 14, pp. 606–609, 1983. View at Google Scholar · View at Scopus
  68. J. C. Barton, N. H. Barton, and T. J. Alford, “Diagnosis of hemochromatosis probands in a community hospital,” The American Journal of Medicine, vol. 103, no. 6, pp. 498–503, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. M. S. Murphy and C. H. Walsh, “Thyroid function in haemochromatosis,” Irish Journal of Medical Science, vol. 173, no. 1, pp. 27–29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. A. E. Stocks and L. W. Powell, “Pituitary function in idiopathic haemochromatosis and cirrhosis of the liver,” The Lancet, vol. 300, no. 7772, pp. 298–300, 1972. View at Publisher · View at Google Scholar · View at Scopus
  71. L. J. Siemons and C. H. Mahler, “Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion,” Journal of Clinical Endocrinology and Metabolism, vol. 65, no. 3, pp. 585–587, 1987. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Gama, M. J. Smith, J. Wright, and V. Marks, “Hypopituitarism in primary haemochromatosis; recovery after iron depletion,” Postgraduate Medical Journal, vol. 71, no. 835, pp. 297–298, 1995. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Wilkinson, “Haemochromatosis associated with arthritis and hypopituitarism,” Annals of Clinical Biochemistry, vol. 33, no. 2, pp. 171–173, 1996. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Hudec, M. Grigerova, and C. H. Walsh, “Secondary hypothyroidism in hereditary hemochromatosis: recovery after iron depletion,” Thyroid, vol. 18, no. 2, pp. 255–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. A. E. Stocks and F. I. R. Martin, “Pituitary function in haemochromatosis,” The American Journal of Medicine, vol. 45, no. 6, pp. 839–845, 1968. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Boelaert, P. R. Newby, M. J. Simmonds et al., “Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease,” The American Journal of Medicine, vol. 123, no. 2, pp. 183–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Wiebolt, R. Achterbergh, A. den Boer et al., “Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients,” European Journal of Endocrinology, vol. 164, no. 5, pp. 789–794, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Cindoruk, I. Yetkin, T. Karakan, and U. Kandilci, “The prevalence of autoimmune hepatitis in Hashimoto's thyroiditis in a Turkish population,” Acta Gastro-Enterologica Belgica, vol. 65, no. 3, pp. 143–145, 2002. View at Google Scholar · View at Scopus
  79. L. M. Teixeira, R. Nisihara, S. R. D. R. Utiyama et al., “Screening of celiac disease in patients with autoimmune thyroid disease from Southern Brazil,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 58, no. 6, pp. 625–629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Radetti, C. Paganini, L. Gentili et al., “Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus,” Acta Diabetologica, vol. 32, no. 2, pp. 121–124, 1995. View at Publisher · View at Google Scholar · View at Scopus
  81. E. McCanlies, L. A. O'Leary, T. P. Foley et al., “Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 5, pp. 1548–1551, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. P. S. N. Menon, B. Vaidyanathan, and M. Kaur, “Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus,” Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. 3, pp. 279–286, 2001. View at Google Scholar · View at Scopus
  83. E. Biró, Z. Szekanecz, L. Czirjk et al., “Association of systemic and thyroid autoimmune diseases,” Clinical Rheumatology, vol. 25, no. 2, pp. 240–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Morimoto, Y. Kato, Y. Ishida et al., “Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis,” Nihon Shokakibyo Gakkai Zasshi, vol. 81, no. 1, pp. 117–120, 1984. View at Google Scholar · View at Scopus
  85. A. Bush, H. Mitchison, R. Walt, J. H. Baron, A. W. Boylston, and J. A. Summerfield, “Primary biliary cirrhosis and ulcerative colitis,” Gastroenterology, vol. 92, no. 6, pp. 2009–2013, 1987. View at Google Scholar · View at Scopus
  86. F. Tada, M. Abe, H. Nunoi et al., “Ulcerative colitis complicated with primary biliary cirrhosis,” Internal Medicine, vol. 50, no. 20, pp. 2323–2327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. J.-M. Anaya, L. Gómez, and J. Castiblanco, “Is there a common genetic basis for autoimmune diseases?” Clinical and Developmental Immunology, vol. 13, no. 2–4, pp. 185–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. P. Desai and S. Karandikar, “Autoimmune thyroid disease in childhood: a study of children and their families,” Indian Pediatrics, vol. 36, no. 7, pp. 659–668, 1999. View at Google Scholar · View at Scopus
  89. M. Dittmar, C. Libich, T. Brenzel, and G. J. Kahaly, “Increased familial clustering of autoimmune thyroid diseases,” Hormone and Metabolic Research, vol. 43, no. 3, pp. 200–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Zandman-Goddard and Y. Shoenfeld, “Hyperferritinemia in autoimmunity,” The Israel Medical Association Journal, vol. 10, no. 1, pp. 83–84, 2008. View at Google Scholar · View at Scopus
  91. V. Herbert, E. Jayatilleke, S. Shaw et al., “Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation,” Stem Cells, vol. 15, no. 4, pp. 291–296, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. P. Nielsen, U. Günther, M. Dürken, R. Fischer, and J. Düllmann, “Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance,” Journal of Laboratory and Clinical Medicine, vol. 135, no. 5, pp. 413–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. D. A. Lipschitz, J. D. Cook, and C. A. Finch, “A clinical evaluation of serum ferritin as an index of iron stores,” The New England Journal of Medicine, vol. 290, no. 22, pp. 1213–1216, 1974. View at Publisher · View at Google Scholar · View at Scopus
  94. D. J. Piñero, J. Hu, B. M. Cook, R. C. Scaduto Jr., and J. R. Connor, “Interleukin-1β increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1497, no. 3, pp. 279–288, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. S. J. Walsh and L. M. Rau, “Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States,” American Journal of Public Health, vol. 90, no. 9, pp. 1463–1466, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Niederau, R. Fischer, A. Sonnenberg, W. Stremmel, H. J. Trampisch, and G. Strohmeyer, “Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis,” The New England Journal of Medicine, vol. 313, no. 20, pp. 1256–1262, 1985. View at Publisher · View at Google Scholar · View at Scopus
  97. G. S. Cooper, J. Wither, T. Mckenzie et al., “The prevalence and accuracy of self-reported history of 11 autoimmune diseases,” Journal of Rheumatology, vol. 35, no. 10, pp. 2001–2004, 2008. View at Google Scholar · View at Scopus
  98. S. C. L. Gough and M. J. Simmonds, “The HLA region and autoimmune disease: associations and mechanisms of action,” Current Genomics, vol. 8, no. 7, pp. 453–465, 2007. View at Publisher · View at Google Scholar · View at Scopus